SCLC | Where are the weaknesses and symptoms of cancer cells? | Increase survival rate | Small cell Lung cancer | Stage | Stage 0 | Stage 1 | Stage 2 | Stage 3 | Stage 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |
Solamargine activates receptors that are turned off by cancer cells, allowing cancer cells to modulate again.
Solamargine modulates the anti-modulates genes of cancer cells, making cancer cells less resistant.
Reduced drug resistance.
When cancer cells are less resistant to drugs, chemotherapy becomes more effective.
Solamargine modulates the mutated genes in cancer cells and then initiates cancer cell apoptosis to achieve anti-cancer effects.
Solamargine combined with which chemotherapy drugs are more effective in treating cancer cells?
Solamargine vs cancer
Solamargine vs cancer
The picture shows the death of cancer cells.
The black and black parts are cancer cell nuclei.
Even if the nucleus ruptures, the cancer cells will die.
The figure shows that cancer cells can cause death.
The figure shows that cancer cells can cause death.
The figure shows that the death of lung cancer cells is relatively slow, and it will not be obvious until eight hours later.
The figure shows that the death of liver cancer cells is very obvious, even more obvious in eight hours.
The graph shows that breast cancer cells die faster. It was obvious from the beginning that breast cancer is easy to treat, and patients with breast cancer need not worry.
Best Chemotherapy Adjuvant (1+1>487%)
Effectively improve chemotherapy effect and treatment.
ANTI-CANCER
Patent protection in 32 nations.
A comparison study showing Solamargine vs. other therapeutic drugs with respect to lung cancer cells.
A comparison study showing Solamargine vs. other chemotherapeutic drugs with respect to breast cancer cells.
SR-T100 combination therapy with effective result against breast cancer cells.
Combination Therapy | Research results for lung cancer cells.
A. Chemotherapy (100μM), 16% of cancer cell apoptosis.
B. Alone SM (4.8μM), 28% of cancer cell apoptosis.
C. SM (4.80μM) + Chemotherapy (40μM), 66% of cancer cells apoptosis.
D. SM (4.80μM) + Chemotherapy (100μM), 78% of cancer cell apoptosis.
SM has a clearing effect better than Chemotherapy.
The combined treatment of Solamargine and Chemotherapy significantly increased the apoptosis of lung cancer cells.
SM (4.8μM) + Chemotherapy (40μM), increased from 16% to 66% (up to 4.125 times).
SM (4.8μM) + Chemotherapy (100μM), increased from 16% to 78% (up to 4.875 times).
Reorganized from: BBRC. Action of Solamargine on TNFs and drug-resistant human lung cancer cells 2004.
survival rate | cancer | Contents survival rate | cancer | Etymology and definitions survival rate | cancer | Signs and symptoms survival rate | cancer | Local symptoms survival rate | cancer | Systemic symptoms survival rate | cancer | Metastasis survival rate | cancer | Causes survival rate | cancer | Chemicals survival rate | cancer | Diet and exercise survival rate | cancer | Infection survival rate | cancer | Radiation survival rate | cancer | Heredity survival rate | cancer | Physical agents survival rate | cancer | Hormones survival rate | cancer | Autoimmune diseases survival rate | cancer | Pathophysiology survival rate | cancer | Genetics survival rate | cancer | Epigenetics survival rate | cancer | Metastasis survival rate | cancer | Metabolism survival rate | cancer | Diagnosis survival rate | cancer | Classification survival rate | cancer | Prevention survival rate | cancer | Dietary survival rate | cancer | Medication survival rate | cancer | Vaccination survival rate | cancer | Screening survival rate | cancer | Recommendations survival rate | cancer | Genetic testing survival rate | cancer | Management survival rate | cancer | Cancer survival rate | cancer | Radiation survival rate | cancer | Surgery survival rate | cancer | Palliative care survival rate | cancer | Immunotherapy survival rate | cancer | Laser therapy survival rate | cancer | Alternative medicine survival rate | cancer | Prognosis survival rate | cancer | Epidemiology survival rate | cancer | History survival rate | cancer | Society and culture survival rate | cancer | Economic effect survival rate | cancer | Workplace survival rate | cancer | Research survival rate | cancer | Pregnancy survival rate | cancer | Other animals survival rate | cancer | Notes survival rate | cancer | Further reading survival rate | cancer | External links Small cell Lung cancer | SCLC | survival rate | Contents Small cell Lung cancer | SCLC | survival rate | Etymology and definitions Small cell Lung cancer | SCLC | survival rate | Signs and symptoms Small cell Lung cancer | SCLC | survival rate | Local symptoms Small cell Lung cancer | SCLC | survival rate | Systemic symptoms Small cell Lung cancer | SCLC | survival rate | Metastasis Small cell Lung cancer | SCLC | survival rate | Causes Small cell Lung cancer | SCLC | survival rate | Chemicals Small cell Lung cancer | SCLC | survival rate | Diet and exercise Small cell Lung cancer | SCLC | survival rate | Infection Small cell Lung cancer | SCLC | survival rate | Radiation Small cell Lung cancer | SCLC | survival rate | Heredity Small cell Lung cancer | SCLC | survival rate | Physical agents Small cell Lung cancer | SCLC | survival rate | Hormones Small cell Lung cancer | SCLC | survival rate | Autoimmune diseases Small cell Lung cancer | SCLC | survival rate | Pathophysiology Small cell Lung cancer | SCLC | survival rate | Genetics Small cell Lung cancer | SCLC | survival rate | Epigenetics Small cell Lung cancer | SCLC | survival rate | Metastasis Small cell Lung cancer | SCLC | survival rate | Metabolism Small cell Lung cancer | SCLC | survival rate | Diagnosis Small cell Lung cancer | SCLC | survival rate | Classification Small cell Lung cancer | SCLC | survival rate | Prevention Small cell Lung cancer | SCLC | survival rate | Dietary Small cell Lung cancer | SCLC | survival rate | Medication Small cell Lung cancer | SCLC | survival rate | Vaccination Small cell Lung cancer | SCLC | survival rate | Screening Small cell Lung cancer | SCLC | survival rate | Recommendations Small cell Lung cancer | SCLC | survival rate | Genetic testing Small cell Lung cancer | SCLC | survival rate | Management Small cell Lung cancer | SCLC | survival rate | Chemotherapy Small cell Lung cancer | SCLC | survival rate | Radiation Small cell Lung cancer | SCLC | survival rate | Surgery Small cell Lung cancer | SCLC | survival rate | Palliative care Small cell Lung cancer | SCLC | survival rate | Immunotherapy Small cell Lung cancer | SCLC | survival rate | Laser therapy Small cell Lung cancer | SCLC | survival rate | Alternative medicine Small cell Lung cancer | SCLC | survival rate | Prognosis Small cell Lung cancer | SCLC | survival rate | Epidemiology Small cell Lung cancer | SCLC | survival rate | History Small cell Lung cancer | SCLC | survival rate | Society and culture Small cell Lung cancer | SCLC | survival rate | Economic effect Small cell Lung cancer | SCLC | survival rate | Workplace Small cell Lung cancer | SCLC | survival rate | Research Small cell Lung cancer | SCLC | survival rate | Pregnancy Small cell Lung cancer | SCLC | survival rate | Other animals Small cell Lung cancer | SCLC | survival rate | Notes Small cell Lung cancer | SCLC | survival rate | Further reading Small cell Lung cancer | SCLC | survival rate | External links